Rentschler will invest €14m to expant the biomanufacturing capbilities at its Laupheim site. At the same time it has sold its pharmaceutical manufacturing business to Riemser Arzneimittel, which will expand its contract manufacturing business with the acquisition.
Rentschler
Thursday, 10 July 2008
Rentschler to expand biomanufacturing and exit pharma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment